Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for symptomatic treatment of cerebellar ataxia
2008-005167-33Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cerebellar ataxia (CA) comparing Gabapentin with Placebo (2 arms). Primary endpoint: Change in SARA score between week 0 and week 7. Started Mar 2010; status: completed.
02
Drugs
gabapentin
03
Conditions
cerebellar ataxia (CA)
Beyond the preview
Go deeper on 2008-005167-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005167-33.